Gemac
St Jean D'Illac, FR· latest recorded location
GEMAC is named on 3 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 3
- Published applications
- 5
- Inventors
- 3
- Granted in 2026 so far
- 0
- Most recent grant
- 30 Jun 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
By publication year.
Technology areas
Share of 8 documents
Recent patents
- Polycomplexes of poly-lysine compounds for preventing and/or combatting amyotrophic lateral sclerosis30 Jun 2020US 10,695,437 B2
- Method for identifying and characterizing polylysine compounds11 Dec 2018US 10,151,689 B2
- Method and kit for following neurodegenerative diseases27 Mar 2007US 7,195,881 B2
- Polycomplexes of poly-lysine compounds for preventing and/or combatting amyotrophic lateral sclerosis21 Mar 2019US 2019/0083640 A1
- Method for identifying and characterizing polylysine compounds24 Aug 2017US 2017/0241903 A1
- Composition Designed For The Treatment Of Multiple Sclerosis31 Dec 2009US 2009/0325856 A1
- Composition intended for the treatment of amyotrophic lateral sclerosis24 Dec 2009US 2009/0318384 A1
- Method and kit for following neurodegenerative diseases29 Apr 2004US 2004/0082015 A1
Most cited
By later US patents